Advancing TIDES Manufacturing for Late-Stage and Commercial Readiness

Advancing TIDES Manufacturing for Late-Stage and Commercial Readiness

As TIDES programs advance toward commercialization, manufacturing readiness is becoming increasingly important. Download this free whitepaper to explore strategies for scaling peptide and oligonucleotide manufacturing, strengthening supply continuity, accelerating CMC execution, and preparing for evolving industry demands. mcottam Thu, 05/21/2026 - 15:45

As TIDES programs advanc

Industry Context

This intelligence report covers the biotech sector in US.

Data Source

Source: FierceBiotech View original